The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York OncLive's FDA Approval Report: The Regulatory Rundown for March 2025 OncLive The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype Bpc 157 bone healing: 2025's Crucial Warning. New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,